XtalPi Inc.

Sep 09, 2025

XtalPi AI Drug Discovery Collaboration Reaches Milestone as PharmaEngine's Novel PRMT5 Inhibitor PEP08 Receives Clinical Trial Approvals

Aug 27, 2025

XtalPi Holdings Announces 2025 Interim Results

Aug 18, 2025

XtalPi Holdings Limited to Announce 2025 Interim Results on August 27, 2025

Jun 29, 2025

XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and Materials Science Simulations

Jan 09, 2025

UCB partners with Ailux Biologics, a Division of XtalPi, on Biologics AI Platform

Oct 10, 2024

Ailux Biologics, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform

Sep 24, 2024

XtalPi Launches Computational Chemistry Software for Drug Discovery: XMolGen and XFEP

Mar 27, 2024

XtalPi to Present the Latest Progress of Its AI Cancer Vaccine Design Platform at AACR 2024

Jan 30, 2024

XtalPi Unveils Ailux: A New Chapter in AI-Powered Biologics Discovery

Jan 13, 2021

XtalPi to Present at the 39th Annual J.P. Morgan Healthcare Conference

Sep 28, 2020

AI Drug R&D Startup XtalPi Announces Over 300 Million Series C Investment Led by SoftBank Vision Fund, PICC Capital, and Morningside

Mar 11, 2020

XtalPi Announces Strategic Collaboration with Porton to Offer Prediction-Guided Crystallization and Drug Solid-State Research Services